Day: May 29, 2024

Presentation and Live Webcast to be Held June 4, 2024, at 10:15 am ET THE WOODLANDS, Texas, May 29, 2024 (GLOBE NEWSWIRE) — Howard Hughes Holdings Inc. (NYSE: HHH) announced today that Chief Financial Officer Carlos Olea will participate in a presentation moderated by Alex Goldfarb from Piper Sandler at NAREIT’s REITweek 2024 Investor Conference in New York City on Tuesday, June 4, 2024, at 10:15 am ET. HHH’s live presentation will be accessible via audio webcast using the link below. Upon completion of the presentation, an on-demand replay will be available for a period of 30 days. Howard Hughes Holdings Inc. PresentationDate: Tuesday, June 4, 2024Time: 10:15 am ETAudio Webcast Link: https://vimeo.com/event/4280082/ About Howard Hughes Holdings Inc.Howard Hughes Holdings Inc. owns, manages, and develops commercial,...

MALVERN, Pa., May 29, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the Company will present at the 2024 BIO International Convention taking place in San Diego, CA from June 3 – 6, 2024. During the conference, Ocugen’s leadership team will host meetings with potential partners and pharmaceutical executives to explore opportunities for the Company’s dynamic pipeline addressing unmet medical needs—particularly its first-in-class ophthalmic modifier gene therapy and regenerative cell therapy platforms. “We are excited to return to BIO this year and showcase the significant advancements we’ve achieved both clinically and strategically,” said Dr. Shankar...

CEO Cameron Chell to Highlight the Role of Drones and Draganfly in the New Global Economic and Political Reality Los Angeles, CA, May 29, 2024 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A), a leader in drone technology and unmanned aerial vehicle (UAV) solutions, will be participating in the Centurion One Los Angeles Summit, held at the Beverly Hills Hotel from June 5th to June 6th, 2024, in Beverly Hills, California. The Centurion One Los Angeles Summit is an event that brings together industry-leading companies along with thought-provoking expert panels. Following the success of the 2023 Los Angeles Summit, the 2024 event will feature both public and private companies from different industries presenting to an audience of retail, venture capital, family office, private equity firms, high-net-worth individuals,...

TORONTO, May 29, 2024 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) is pleased to announce the most recent assay results from 14 drill holes representing 4,105 metres (“m”) of drilling from the 2022-2024 resource expansion program at the Wawa Gold Project. Since the resource expansion drilling program began in 2021, Red Pine has now completed approximately 67,000 m of additional drilling in the current program for the new mineral resource estimate update. Of these holes, approximately 60,300 m have now been reported and the Company expects additional results to follow over the coming months from the remaining core. Drilling Highlights (Table 1, Figures 1-3):5.58 grams per tonne (“g/t”) gold over 18.44 m, including 6.18 g/t gold over 1.11 m, and 72.20 g/t gold over 0.88 m...

Castellum, Inc. Announces Leadership ChangesMark Fuller, co-founder of Castellum and Chief Executive Officer (“CEO”), will be stepping down as CEO effective July 1, 2024, to pursue other interests. Glen Ives, currently Chief Operating Officer of Castellum, will become the new CEO, effective July 1, 2024 – http://castellumus.comVIENNA, Va., May 29, 2024 (GLOBE NEWSWIRE) — Castellum, Inc. (the “Company” or “Castellum”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces two leadership changes. Mark Fuller, co-founder of Castellum and Chief Executive Officer (“CEO”), will be stepping down as CEO effective July 1, 2024, to pursue other interests. Glen Ives, currently Chief Operating Officer of Castellum, will become the new CEO, effective...

Opportunity for Iopofosine Expansion Within Areas of High Unmet Need in Non-Hodgkin’s Lymphoma Establishes Partnership With One of the Largest Cancer Research and Treatment Organizations in the U.S. FLORHAM PARK, N.J., May 29, 2024 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, announced today a strategic partnership with City of Hope Cancer Center, one of the largest cancer research and treatment organizations in the United States. The collaboration will focus on the clinical development of Cellectar’s lead radioconjugate asset, iopofosine I 131, in mycosis fungoides (MF), a rare form of non-Hodgkin’s lymphoma (NHL) that affects the skin and, in some patients,...